Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?

Diabetologia

Volumn 55, Issue 4, 2012, Pages 1151-1155

  Fleming, T ^a   Cuny, J ^a   Nawroth, G ^a   Djuric, Z ^a   Humpert, P M ^a   Zeier, M ^a   Bierhaus, A ^a   Nawroth, P P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

AGEs; Glycation; Metabolism; Oxidative stress; Pathophysiology

Indexed keywords

ALDEHYDE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; METHYLGLYOXAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIOSEPHOSPHATE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC PATIENT; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GLUCOSE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PYRUVALDEHYDE;

EID: 84860232014     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2452-1     Document Type: Article

References (10)

1. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
2. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
3. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN, DCCT/EDIC Research Group (2008) Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited. Diabetes 57:995-1001
4. Richard JP (1993) Mechanism for the formation of methylglyoxal from triosephosphates. Biochem Soc Trans 1:549-553
5. Beutler E (1984) Red cell metabolism. A manual of biochemical methods, 3rd edn. Grune & Stratton, New York, USA
6. McLellan AC, Phillips SA, Thornalley PJ (1992) The assay of methylglyoxal in biological systems by derivatization with 1, 2-diamino-4, 5-dimethoxybenzene. Anal Biochem 206:17-23
7. Tegos C, Bulter E (1980) Red cell glycolytic intermediates in diabetic patients. J Lab Clin Med 96:85-89
8. McLellan AC, Thornalley PJ, Benn J, Sonksen PH (1994) Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 87:21-29
9. Lee HJ, Howell SK, Sanford RJ, Beisswenger PJ (2005) Methyl-glyoxal can modify GAPDH activity and structure. Ann N YAcad Sci 1043:135-145
10. Beisswenger PJ, Howell SK, Smith K, Szewegold BS (2003) Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 1637:98-106